Cardioprotective radiotherapy: The circadian way

Medical Hypotheses

Volumn 78, Issue 3, 2012, Pages 353-355

  Gupta, Deepak ^a   Shukla, Pragya ^a   Munshi, Anusheel ^a   Aggarwal, Jai Prakash ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; BETA 2 ADRENERGIC RECEPTOR; ENDOTHELIN 1; NITRIC OXIDE; NORADRENALIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VON WILLEBRAND FACTOR;

ADRENALIN RELEASE; ARTICLE; BLOOD VISCOSITY; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAPILLARY PERMEABILITY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CHRONOTHERAPY; CIRCADIAN RHYTHM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; ELECTROCARDIOGRAM; ERYTHEMA; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HUMAN; HYPOTHESIS; IMAGE GUIDED RADIOTHERAPY; INFLAMMATORY INFILTRATE; LEUKOCYTE AGGREGATION; LEUKOCYTE COUNT; NORADRENALIN RELEASE; POSTMENOPAUSE; PROTON THERAPY; RADIATION INJURY; SUDDEN DEATH; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; VASODILATATION;

BREAST NEOPLASMS; CHRONOBIOLOGY PHENOMENA; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MYOCARDIUM; OXYGEN; RADIOTHERAPY; TIME FACTORS; VASODILATION;

EID: 84856467871     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.12.009     Document Type: Article

References (49)

1. Overgaard M., Hansen P.S., Overgaard J., Rose C., Andersson M., Bach F. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997, 337:949-955.
2. Ragaz J., Jackson S., Le N. Adjuvant radiotherapy, chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997, 337:956.
3. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Effects of radiotherapy, of differences in the extent of surgery for early breast cancer on local recurrence, 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.
4. Munshi Anusheel, Talapatra Kaustav, Dutta Debnarayan Breast cancer radiotherapy and cardiac risk. Oncol Rev 2010, 4:137-146.
5. Darby S., McGale P., Peto R., Granath F., Hall P., Akbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women. BMJ 2003, 326:256-257.
6. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2005;355:1757-1770.
7. Campana F., Kirova Y.M., Rosenwald J.C. Breast radiotherapy in the lateral decubitus position: a technique to prevent lung and heart irradiation. Int J Radiat Oncol Biol Phys 2005, 61:1348-1354.
8. Griem K.L., Fetherston P., Kuznetsova M. Three-dimensional photon dosimetry: a comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 2003, 57:891-899.
9. Holland R., Veling S.H., Mravunac M., Hendriks J.H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
10. Fisher B., Anderson S., Bryant J., Margolese R.G., Deutsch M., Fisher E.R., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
11. Munshi A. Breast cancer radiotherapy and cardiac risk: 15 year paradox!. J Cancer Res Ther 2007, 3:190-192.
12. Marti V., Garcia J., Auge J.M., et al. Coronary arterial spasm and cardiac arrest following mediastinal radiation therapy for Hodgkin's disease. Chest 1991, 100:1180-1181.
13. Halid E., Faisel K., Mclaren M., Kennedy G., Belch J.F. Circadian variation in vascular tone and endothelial cell function in normal males. Clin Sci 2002, 102:547-552.
14. Smolensky M.H. Aspects of human chronopathology. Biological Rhythms and Medicine: Cellular, Metabolic, Physiopathologic, and Pharmacologic Aspects 1983, 131-209. Springer-Verlag, New York. A. Reinberg, M.H. Smo-Iensky (Eds.).
15. Muller L.E., Stone P.H., Turi Z.G., Rutherford I.D., Czeisler C.A., Parker C., et al. MILIS study group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985, 313:1315-1322.
16. Master A.M. The role of effort and occupation (including physicians) in coronary occlusion. IAMA 1960, 174:942-948.
17. Regional Office of Europe. World Health Organization. Myocardial infarction community registers: results of a WHO international collaborative study coordinated by the regional office for Europe. Public Health in Europe, No. 5, Copenhagen, 1976;1-232.
18. Rocco M.B., Barry J., Campbell S., et al. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987, 75:395-400.
19. Rocco M.B., Nadel E.G., Selwyn A.P. Circadian rhythms and coronary artery disease. Am J Cardiol 1987, 59(Suppl 1):13C-17C.
20. Gottlieb S.O. Circadian patterns of myocardial ischemia: pathophysiologic and therapeutic considerations. J Cardiovasc Pharmacol 1988, 12:S18-S21.
21. Muller J.E., Tofler G.H., Stone P.H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989, 79:733-743.
22. Turton M.B., Deegan T. Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects. Clin Chim Acta 1974, 55:389-397.
23. Millar-Craig M.W., Bishop C.N., Raftery E.B. Circadian variation of blood pressure. Lancet 1978, 1:795-797.
24. Floras J.S., Jones J.V., Johnston J.A., et al. Arousal and the circadian rhythm of blood pressure. Clin Sci Mol Med 1978, 55:395-397.
25. Davies A.B., Bala-Subramanian V., Cashman P.M.M., Raftery E.B. Simultaneous recording of continuous arterial pressure, heart rate, and ST segment in ambulant patients with stable angina pectoris. Br Heart J 1983, 50:85-91.
26. Nademanee K., Christenson P.D., Robertson H.A., et al. Role of parasympathetic activity in the diurnal variation of heart rate in man: heart rate spectrum analysis of Holter monitoring. Circulation 1988, 78(Suppl II):610. [Abstract].
27. Fajardo L.F., Stewart J.R. Experimental radiation-induced heart disease. Am J Pathol 1970, 59:299-316.
28. Stewart J.R., Fajardo L.F. Radiation-induced heart disease: clinical and experimental aspects. Radiol Clin North Am 1971, 9:511-531.
29. Stewart J.R., Fajardo L.F., Gillette S.M. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995, 31:1205-1211.
30. Brosius F.C., Waller B.F., Roberts W.C. Radiation heart disease: analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med 1981, 70:519-530.
31. Bradley E.W., Zook B.C., Casarett G.W. Coronary arteriosclerosis and atherosclerosis in fast neutron or photon irradiated dogs. Int J Radiat Oncol Biol Phys 1988, 7:1103-1108.
32. Etsuda H., Takase B., Uehata A., Kusano H., Hamabe A. Morning attenuation of endotheliumdependent, flow-mediated dilation in healthy young men: possible connection to morning peak of cardiac events? Clin. Cardiol 1999, 22:417-421.
33. Quyyumi A.A., Panza J.A., Lakatos E., et al. Circadian variation in ischemic events: causal role of variation in ischemic threshold due to changes in vascular resistance. Circulation 1988, 78S:331. Abstract.
34. Tofler G.H., Brezinski D., Schafer A.I., et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987, 316:1514-1518.
35. Angleton P., Chandler W.L., Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989, 79:101-106.
36. Bridges A.B., McLaren M., Fisher T.C., Saniabadi A., Belch J.J.F. Orcadian variation of endothelial cell function, red blood cell deformability and dehydrothromboxane B2 in healthy volunteers. Blood Coagul Fibrinolysis 1991, 2:447-452.
37. Ehrly A.M., Jung G. Orcadian rhythm of human blood viscosity. Biorheology 1973, 10:577-583.
38. Tofler G.H., Brezinski D., Schafer A.I., et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987, 316:1514-1518.
39. Willich S.N., Sintonen S.P., Bhatia S.S., et al. Morning increase of platelet aggregability in patients with coronary artery disease. J Am Coll Cardiol 1988, 11S:204. Abstract.
40. Angleton P., Chandler W.L., Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989, 79:101-106.
41. Ogawa H., Yasue H., Oshima S. Circadian variation of plasma fibrinopeptide A levels in patients with variant angina. Circulation 1988, 78S:331. Abstract.
42. Petralito A., Mangiafico R.A., Gibino S., Cuffari M.A., Miano M.F., Fiore C.E. Daily modifications of plasma fibrinogen, platelets, aggregation, Howell's time, PTT, TT and antithrombin III in normal subjects and in patients with vascular disease. Chronobiologia 1982, 9:195-201.
43. Bridges A.B., Scott N.A., Mcneiixf G.P., Pringlef T.H., Belch J.J.F. Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Eur Heart J 1992, 13:1632-1636.
44. McCord J.M. Oxygen-derived free radicals in post-ischaemic tissue injury. N Engl J Med 1985, 312:159-163.
45. Barrowcliffe T.W., Gray E., Kerry P.J., Gutteridge J.M.C. Lipid peroxides, lipoproteins and thrombosis. Life Chem Rep 1985, 3:174-188.
46. Finlayson D.C., Dagher F.J., Vandam L.D. Diurnal variation in blood volume of man. J Surg Res 1964, 4:286-288.
47. Chrusciel P., Goch A., Banach M., Mikhailidis D.P., Rysz J., Goch J.H. Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit 2009, 15:203-208.
48. Walters J.F., Hamptona S.M., Deanfield B., Donald A.E., Skene D.J., Ferns G.A. Circadian variation in endothelial function is attenuated in postmenopausal women. Maturitas 2006, 54:294-303.
49. Giusti M., Fazzuoli L., Cavallero D., Valenti S. Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy. Gynecol Endocrinol 2002, 16:407-412.